TGA Conformity Certification for Device OEMs — What It Actually Covers

If you are an OEM brand looking to enter the Australian market with a medical device, you have probably encountered the term "TGA conformity assessment." It appears on supplier websites, in RFQs, and in regulatory checklists. But what does it actually mean — and what does it not mean?

Here is a practical breakdown for device brands evaluating manufacturing partners.

What a TGA conformity certificate is

Australia's Therapeutic Goods Administration (TGA) requires certain medical devices to undergo conformity assessment before they can be supplied in Australia. A conformity assessment certificate confirms that the manufacturer's quality management system and technical documentation meet the Essential Principles for safety and performance — and that an independent conformity assessment body has verified this.

For a contract manufacturer, holding a TGA conformity certificate means the TGA has reviewed and approved the manufacturer's processes for a specific device category. It is not a general "TGA-approved factory" badge. The scope matters enormously — and it is the first thing a brand should verify.

What DMT's certificate covers

DMT holds TGA conformity assessment certificate AU Q00557, issued 12 May 2026. The scope is medicinal cannabis vaping devices, classified as Class IIb medical devices. This certificate confirms that DMT's quality management system — built on ISO 13485:2016 certification by BSI and audited through MDSAP — meets Australian requirements for design, production, and post-market obligations within that specific device category.

For a brand engaging DMT as an ODM for a regulated vaporizer destined for Australia, this means DMT's conformity assessment can be referenced in the brand's own ARTG application — reducing the regulatory burden and accelerating the path to market. The certificate is a regulatory asset, not just a wall decoration.

What the certificate does not cover

A TGA conformity certificate is device-class specific. DMT's AU Q00557 covers medicinal cannabis vaping devices (Class IIb). It does not extend to other device classes, unrelated product categories, or devices outside the defined scope. Brands developing products that fall outside this scope will need their own conformity assessment pathway.

This is why regulatory diligence matters: a manufacturer waving a certificate without specifying its scope is not doing you a favour. The scope line on the certificate is the only line that counts.

How TGA conformity fits into the broader quality picture

TGA conformity assessment does not exist in isolation. It sits within a layered quality framework that starts with the manufacturer's core quality management system.

At DMT, the foundation is ISO 13485:2016 — covering design controls, risk management, purchasing, production, inspection, and full batch traceability. On top of that, MDSAP certification (BSI 717779) provides multi-jurisdiction audit recognition across five regulatory authorities: US FDA, Health Canada, Australia TGA, Brazil ANVISA, and Japan PMDA. The TGA conformity certificate is the Australian-specific layer that confirms compliance for a defined product category under that existing quality framework.

Together, these three certifications mean a brand gets more than a factory — it gets a regulatory-quality manufacturing partner whose documentation can support submissions across multiple markets, not just one.

What this means for your OEM decision

When evaluating a contract manufacturer for regulated markets, ask these specific questions:

• What is the exact scope of the TGA certificate — which device class, which product category?
• Can the manufacturer's conformity assessment be referenced in your ARTG application?
• Is the certificate backed by ISO 13485 and MDSAP, or is it a standalone document?
• How long has the manufacturer been operating under this quality system?

A certificate that answers these questions clearly is a genuine regulatory asset. One that raises more questions than it answers is a liability.

DMT's approach is straightforward: our certifications are specific, auditable, and designed to support our brand partners' regulatory pathways — starting with the quality system and extending through the conformity assessment that matters for your target market.

Request OEM / ODM Quote → · Portfolio and certification details available under NDA.

Sources

• Therapeutic Goods Administration (TGA), Australia — conformity assessment under the Therapeutic Goods Act 1989
• DMT certification register: ISO 13485:2016 (BSI), MDSAP 717779 (BSI), TGA conformity assessment AU Q00557 (Class IIb, issued 12 May 2026)